Production (Stage)
scPharmaceuticals Inc.
SCPH
$3.64
$0.092.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.84% | -0.64% | 1.28% | -62.72% | -49.74% |
| Total Receivables | 140.02% | 161.10% | 120.77% | 279.88% | 92.14% |
| Inventory | 47.73% | 57.27% | 154.20% | 162.48% | 164.35% |
| Prepaid Expenses | 57.42% | 45.69% | 113.62% | 26.98% | -18.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.76% | 13.89% | 18.20% | -44.85% | -39.59% |
|
|
|||||
| Total Current Assets | 16.76% | 13.89% | 18.20% | -44.85% | -39.59% |
| Net Property, Plant & Equipment | -8.46% | -8.91% | -12.26% | 232.35% | 173.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -38.31% | 315.85% | 90.96% | 678.31% | 174.74% |
| Total Assets | 15.94% | 13.80% | 17.88% | -42.67% | -38.41% |
|
|
|||||
| Total Accounts Payable | 84.33% | -2.95% | 48.46% | 347.88% | 66.42% |
| Total Accrued Expenses | 6.88% | 11.20% | 42.33% | 49.08% | 69.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.04% | 35.80% | -6.85% | -28.84% | -56.09% |
| Total Finance Division Other Current Liabilities | 454.50% | 396.60% | -59.50% | -78.92% | -11.90% |
| Total Other Current Liabilities | 454.50% | 396.60% | -59.50% | -78.92% | -11.90% |
| Total Current Liabilities | 32.42% | 13.26% | 39.38% | 94.88% | 59.25% |
|
|
|||||
| Total Current Liabilities | 32.42% | 13.26% | 39.38% | 94.88% | 59.25% |
| Long-Term Debt | 29.62% | 32.31% | 33.55% | 5.96% | 5.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.60% | -13.88% | -10.44% | 29,500.00% | 24,560.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2,807.04% | 566.06% | 316.68% | -66.94% | -85.51% |
| Total Liabilities | 78.31% | 64.51% | 65.67% | 10.77% | 4.51% |
|
|
|||||
| Common Stock & APIC | 19.09% | 19.23% | 19.48% | 2.05% | 2.07% |
| Retained Earnings | -30.73% | -30.26% | -29.95% | -24.07% | -24.27% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -120.87% | -64.21% | -37.51% | -85.42% | -67.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -120.87% | -64.21% | -37.51% | -85.42% | -67.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -120.87% | -64.21% | -37.51% | -85.42% | -67.59% |
|
|
|||||